Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | STAT1 | P42224 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 2/20 | 0.43 |
| ▸ | KDR | P35968 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18783443 | 1.00 | SMN1; SMN2 (0.59) | SMN1; SMN2MAPTLMNANPC1RAB9A | |
| SCHEMBL12593354 | 0.89 | CHRM5 (0.50) | SMN1; SMN2MAPTLMNANPC1RAB9A | |
| SCHEMBL25543964 | 0.89 | MAPT (0.65) | SMN1; SMN2MAPTLMNANPC1RAB9A | |
| SCHEMBL16614434 | 0.88 | SMN1; SMN2 (0.47) | SMN1; SMN2MAPTLMNANPC1RAB9A | |
| SCHEMBL21019110 | 0.86 | NPC1 (0.50) | SMN1; SMN2MAPTNPC1RAB9AKMT2A | |
| SCHEMBL21018826 | 0.86 | SMN1; SMN2 (0.46) | SMN1; SMN2MAPTLMNANPC1RAB9A | |
| SCHEMBL20023677 | 0.86 | SMN1; SMN2 (0.46) | SMN1; SMN2MAPTLMNANPC1RAB9A | |
| SCHEMBL13020815 | 0.86 | ALDH1A1 (0.52) | SMN1; SMN2MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL17409158 | 0.86 | ALDH1A1 (0.52) | SMN1; SMN2MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL6950285 | 0.86 | ALDH1A1 (0.52) | SMN1; SMN2MAPTKMT2AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190157567-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | DOOSAN CORPORATION (KR) | 2019-05-23 | — | — | US | disclosed |
| WO-2015046982-A2 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 주식회사 두산 | 2015-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190157567-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SLC18A3, L1CAM, TMEM109 | SMN1; SMN2 2435/4885MAPT 1370/4885LMNA 3167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.